Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PD 0200390 Dose-ranging Trial: A Randomized, Double-blind, Placebo-controlled, 5-way Crossover, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia

NCT00551148 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00551148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00551148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PD 0200390 Dose-ranging Trial: A Randomized, Double-blind, Placebo-controlled, 5-way Crossover, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
January 31, 2008
Enrollment
92 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

primary insomnia